✦ LIBER ✦

Antiglutamatergic therapy in Alzheimer's disease – effects of lamotrigine

✍ Scribed by S. Tekin; C. Aykut-Bingöl; T. Tanrıdağ; S. Aktan

Publisher: Springer
Year: 1998
Tongue: English
Weight: 147 KB
Volume: 105
Category: Article
ISSN: 1435-1463
DOI: 10.1007/s007020050059

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Measuring target effect of proposed dise

Measuring target effect of proposed disease-modifying therapies in Alzheimer’s disease

✍ Randall J. Bateman; William E. Klunk 📂 Article 📅 2008 🏛 Springer-Verlag 🌐 English ⚖ 165 KB

The effects of group work therapy in pat

The effects of group work therapy in patients with Alzheimer's disease

✍ Junichi Ishizaki; Kenichi Meguro; Hiroshi Ishii; Satoshi Yamaguchi; Masumi Shima 📂 Article 📅 2000 🏛 John Wiley and Sons 🌐 English ⚖ 62 KB 👁 3 views

Imaging treatment effects in Alzheimer's

Imaging treatment effects in Alzheimer's disease

✍ Annalena Venneri 📂 Article 📅 2007 🏛 Elsevier Science 🌐 English ⚖ 600 KB

Development of antiinflammatory therapy

Development of antiinflammatory therapy for Alzheimer's disease

✍ Paul S. Aisen 📂 Article 📅 2002 🏛 John Wiley and Sons 🌐 English ⚖ 82 KB 👁 2 views

Effects of oral physostigmine in Alzheim

Effects of oral physostigmine in Alzheimer's disease

✍ Dr Yaakov Stern; Mary Sano; Richard Mayeux 📂 Article 📅 1987 🏛 John Wiley and Sons 🌐 English ⚖ 476 KB 👁 2 views

Cognitive effects ofl-deprenyl in Alzhei

Cognitive effects ofl-deprenyl in Alzheimer's disease

✍ P. N. Tariot; T. Sunderland; H. Weingartner; D. L. Murphy; J. A. Welkowitz; K. T 📂 Article 📅 1987 🏛 Springer 🌐 English ⚖ 903 KB

Monoamine neurotransmitter systems, along with cholinergic systems, are known to play important roles in cognition, and are disrupted in at least some patients with dementia of the Alzheimer type (DAT). This suggests that monoamine-enhancing drugs might ameliorate cognitive symptoms in certain patie